Cargando…

Genetic prediction of impulse control disorders in Parkinson's disease

OBJECTIVE: To develop a clinico‐genetic predictor of impulse control disorder (ICD) risk in Parkinson's disease (PD). METHODS: In 5770 individuals from three PD cohorts (the 23andMe, Inc.; the University of Pennsylvania [UPenn]; and the Parkinson's Progression Markers Initiative [PPMI]), w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weintraub, Daniel, Posavi, Marijan, Fontanillas, Pierre, Tropea, Thomas F., Mamikonyan, Eugenia, Suh, Eunran, Trojanowski, John Q., Cannon, Paul, Van Deerlin, Vivianna M., Chen‐Plotkin, Alice S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268896/ https://www.ncbi.nlm.nih.gov/pubmed/35762106 http://dx.doi.org/10.1002/acn3.51569

Ejemplares similares

Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson’s Disease
por: Gallagher, Julia, et al.
Publicado: (2021)

Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson’s disease
por: Leyns, Cheryl E. G., et al.
Publicado: (2023)

Characterization of Parkinson’s disease using blood-based biomarkers: A multicohort proteomic analysis
por: Posavi, Marijan, et al.
Publicado: (2019)

Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated
por: Robinson, John L, et al.
Publicado: (2023)

Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia
por: Akhtar, Rizwan S., et al.
Publicado: (2017)

Common neuropathological features underlie distinct clinical presentations in three siblings with hereditary diffuse leukoencephalopathy with spheroids caused by CSF1R p.Arg782His
por: Robinson, John L., et al.
Publicado: (2015)

Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype
por: Cooper, Christine A., et al.
Publicado: (2016)

Tau immunotherapy is associated with glial responses in FTLD-tau
por: Kim, Boram, et al.
Publicado: (2021)

Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain
por: Busch, Johanna I, et al.
Publicado: (2013)

Validating virtual administration of neuropsychological testing in Parkinson disease: a pilot study
por: Weintraub, Daniel, et al.
Publicado: (2023)

Testing for Allele-specific Expression from Human Brain Samples
por: Diaz-Ortiz, Maria E., et al.
Publicado: (2023)

Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration
por: Giannini, Lucia A. A., et al.
Publicado: (2022)

Correction to: Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration
por: Giannini, Lucia A. A., et al.
Publicado: (2023)

Validating virtual administration of neuropsychological testing in Parkinson disease: a pilot study
por: Gallagher, Julia, et al.
Publicado: (2023)

Alzheimer's genetic risk is reduced in primary age‐related tauopathy: a potential model of resistance?
por: McMillan, Corey T., et al.
Publicado: (2018)

Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin
por: Amlie-Wolf, Alexandre, et al.
Publicado: (2015)

Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration
por: Yousef, Ahmed, et al.
Publicado: (2017)

Are Parkinson’s Disease Patients the Ideal Preclinical Population for Alzheimer’s Disease Therapeutics?
por: Tropea, Thomas F., et al.
Publicado: (2021)

Perfusion Imaging of Fatigue and Time-on-Task Effects in Patients With Parkinson’s Disease
por: Liu, Wanting, et al.
Publicado: (2022)

PolyQ Repeat Expansions in ATXN2 Associated with ALS Are CAA Interrupted Repeats
por: Yu, Zhenming, et al.
Publicado: (2011)

APOE and TREM2 regulate amyloid responsive microglia in Alzheimer’s disease
por: Nguyen, Aivi T., et al.
Publicado: (2020)

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
por: Lim, Nicholas S., et al.
Publicado: (2016)

The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort
por: Heilbron, Karl, et al.
Publicado: (2019)

Impulse control disorders in Parkinson's disease
por: Stacy, Mark
Publicado: (2009)

Impulse control disorders in Parkinson’s disease
por: Bhattacharjee, Shakya
Publicado: (2020)

Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis
por: Brettschneider, Johannes, et al.
Publicado: (2012)

TMEM106B deficiency impairs cerebellar myelination and synaptic integrity with Purkinje cell loss
por: Feng, Tuancheng, et al.
Publicado: (2022)

Editorial: Impulse Control Disorders, Impulsivity and Related Behaviors in Parkinson's Disease
por: Rodríguez-Violante, Mayela, et al.
Publicado: (2019)

An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia
por: Berlyand, Yosef, et al.
Publicado: (2016)

Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity
por: Marín-Lahoz, Juan, et al.
Publicado: (2018)

The Pathophysiology of Impulse control Disorders in Parkinson Disease
por: Balarajah, Sharmili, et al.
Publicado: (2013)

Validation of the Japanese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS)
por: Takahashi, Maiko, et al.
Publicado: (2022)

Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson’s Disease?
por: Houeto, Jean-Luc, et al.
Publicado: (2016)

Impulse control disorders in Parkinson's: Sleep disorders and nondopaminergic associations
por: Carbunaru, Samuel, et al.
Publicado: (2018)

From anticipation to impulsivity in Parkinson’s disease
por: Degos, Bertrand, et al.
Publicado: (2022)

Brain Imaging and Impulse Control Disorders in Parkinson’s Disease
por: Roussakis, Andreas–Antonios, et al.
Publicado: (2019)

Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease
por: Martini, Alice, et al.
Publicado: (2019)

Risky decision-making and affective features of impulse control disorders in Parkinson’s disease
por: Martini, Alice, et al.
Publicado: (2017)

Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease (QUIP) and the QUIP-rating scale in a German speaking sample
por: Probst, Catharina Claudia, et al.
Publicado: (2014)

Impulse control disorders and related behaviours (ICD-RBs) in Parkinson's disease patients: Assessment using “Questionnaire for impulsive-compulsive disorders in Parkinson's disease” (QUIP)
por: Sharma, Ashish, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dejarloumpb025no1fk9d19cfo